Browse All

Current Filters

CLEAR FILTER x

TITLE

Author:

Dissecting the Phenotype of CHD2-Associated Epilepsy: A Systematic Review and Individual Participant Data Analysis

Author:Puri, Anabel   Woods, Sean   Brock, Dylan   Karakas, Cemal   

Session Name:P11: Epilepsy/Clinical Neurophysiology (EEG): Epilepsy Syndromes and Genetics  

Topic:Epilepsy/Clinical Neurophysiology (EEG)  

Program Number:P11.008  

Author Institution:Division of Child Neurology, Department of Pediatrics, Norton Children’s Neuroscience Institute, University of Louisville , Louisville, KY  Division of Child Neurology, Department of Pediatrics, Norton Children’s Neuroscience Institute, University of Louisville , Shepherdsville, KY  

A Phase 4, Open-label Study Evaluating the Safety and Tolerability of Once Daily Rimegepant for Episodic Migraine Prevention

Author:Antinew, Jeremias   Fountaine, Robert   Loprinzo, Vittorio   Straghan, Esther   Fullerton, Terence   

Session Name:P11: Emerging Science  

Topic:Headache  

Program Number:P11.008  

Author Institution:Pfizer Inc, Groton, CT  Pfizer Inc, New York, NY  Pfizer Ltd., Surrey, United Kingdom  

Frequency of Abnormal Neurological Examinations in a Subspecialty Headache Clinic: A Retrospective Chart Review

Author:Leung, Sabrina   Iverson, Olivia   Green, Laine   

Session Name:P11: Headache: Clinical Presentation/Diagnosis  

Topic:Headache  

Program Number:P11.009  

Author Institution:Mayo Clinic Alix School of Medicine, Scottsdale, AZ  

A Proof-of-concept Study of TR-012001, a Nasal Levodopa, in Patients with Parkinson’s Disease with OFF Episodes, Without Dopa Decarboxylase Inhibitor

Author:Nomoto, Masahiro   Yabe, Hayato   Ando, Rina   Sumiyoshi, Yasuhiro   Akagi, Takami   Ise, Ryota   Akiyoshi, Yuki   Date, Chizu   Nakano, Satoshi   Suzuki, Ryosuke   

Session Name:P11: Movement Disorders: Therapeutics in Study for Parkinson's Disease  

Topic:Movement Disorders  

Program Number:P11.009  

Author Institution:Saiseikai Imabari Hospital, Imabari, Japan  Saiseikai Matsuyama Hospital, Matsuyama, Ehime, Japan  Ehime University Graduate School of Medicine, Ehime,, Japan  SNLD, Ltd., Tokyo, Japan  Tour de Medication Co., Ltd., Josei, Kagoshima-shi, Kagoshima, Japan  

Neighborhood Disadvantage is Not Associated with Exposure to NMOSD Treatment

Author:Palmer, Kaitlyn   Conway, Devon   Du, Mengke   Aboseif, Albert   Swetlik, Carol   Widmar, Julie   Kunchok, Amy   Miller, Deborah   O'Mahony, Julia   Abbatemarco, Justin   

Session Name:P11: Autoimmune Neurology: NMOSD and MOGAD 2  

Topic:Autoimmune Neurology  

Program Number:P11.009  

Author Institution:Cleveland Clinic, Cleveland, OH  Mayo Clinic Rochester, Rochester, MN  MetroHealth, Cleveland, OH